GlassScriptPhysician profile
Bharat M Tolia
NPI 1770535171
$16,253.56
in general payments reported to CMS, 2019-2025
48 companies · $1,558 in 2025
The $1,558 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,243 · 2020: $1,414 · 2021: $4,731 · 2022: $1,648 · 2023: $1,570 · 2024: $3,092 · 2025: $1,558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,714 · Travel and Lodging: $1,354 · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,713.76 |
| Travel and Lodging | $1,353.93 |
| Education | $151.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,311.01 | 2019-2022 | |
| Sk Life Science, INC. | $2,206.51 | 2020-2025 | |
| Livanova USA, INC. | $1,906.63 | 2019-2024 | Vns Therapy |
| Eisai INC. | $1,104.92 | 2019-2023 | |
| Sunovion Pharmaceuticals INC. | $936.29 | 2019-2022 | |
| Harmony Biosciences LLC | $865.57 | 2020-2025 | Wakix |
| Emd Serono, INC. | $807.82 | 2019-2024 | Mavenclad |
| Catalyst Pharmaceuticals, INC. | $643.93 | 2023-2025 | Fycompa |
| Abbvie INC. | $599.34 | 2021-2025 | Ubrelvy |
| Mdd US Operations, LLC | $564.15 | 2019-2022 | |
| Ucb, INC. | $274.58 | 2019-2025 | Fintepla |
| Amgen INC. | $242.32 | 2019-2021 | |
| Neurelis, INC. | $238.15 | 2021-2025 | Valtoco |
| Teva Pharmaceuticals USA, INC. | $187.35 | 2020-2023 | Austedo Xr |
| Lilly USA, LLC | $173.82 | 2019-2022 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bharat Tolia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.